Tic Disorders
Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994)
Subtype terms (1)
More specific conditions that are subtypes of Tic Disorders in the MeSH hierarchy.
- Tourette Syndrome
49 drugs (31 approved, 18 experimental)
Drugs by status
Phase 3 trials (3)
Phase 2 trials (3)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (13)
- Shire
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- Albany Medical College
- Emory University
- Hoosier Cancer Research Network
- Johns Hopkins University
- New York University
- Parkinson's Disease and Movement Disorders Center
- University of South Florida
- Yale University
- Icahn School of Medicine at Mount Sinai
- Johnson and Johnson
Organization Involved with Phase 3 Indications (11)
- Tasly Pharmaceuticals, Inc.
- Otsuka
- German Research Foundation
- Gottfried Wilhelm Leibniz Universität Hannover
- Nanjing University
- Seoul National University
- Capital Medical University
- Tianjin University of Traditional Chinese Medicine
- Zhejiang University
- Liaoning Hospital of Traditional Chinese Medicine
- Henan Medical University
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (3)